Eli Lilly And Company Earnings

Eli Lilly And Company’s revenue jumped 53.87% since last year same period to $17600.8Mn in the Q3 2025. On a quarterly growth basis, Eli Lilly And Company has generated 13.13% jump in its revenue since last 3-months.

Eli Lilly And Company’s net profit jumped 475.34% since last year same period to $5582.5Mn in the Q3 2025. On a quarterly growth basis, Eli Lilly And Company has generated -1.38% fall in its net profits since last 3-months.

Eli Lilly And Company’s net profit margin jumped 273.92% since last year same period to 31.72% in the Q3 2025. On a quarterly growth basis, Eli Lilly And Company has generated -12.83% fall in its net profit margins since last 3-months.

Eli Lilly And Company’s earning per share (EPS) estimates for the current quarter stand at 6.37 - a 13.95% jump from last quarter’s estimates.

Eli Lilly And Company’s earning per share (EPS) estimates for the current year stand at 6.37.

Eli Lilly And Company’s earning per share (EPS) jumped 60.97% since last year same period to 6.31 in the Q2 2025. This indicates that the Eli Lilly And Company has generated 60.97% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Eli Lilly And Company declared 1.5 dividend per share during the earnings announcement for Q2 2025.